on 06 Jun 2023
Last Applicant/ Owned by
226 Boulevard Voltaire
Paris
FR
75011
Serial Number
97059705 filed on 05th Oct 2021
Registration Number
7076597 registered on 06th Jun 2023
Correspondent Address
Heather Smith-Carra
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of Wilson's disease; Pharmaceutical products for the treatment of Wilson's disease; Chemical preparations for medical purposes, namely, for treatment of Wilson's disease; Chemical preparations for pharmaceutical purposes, namely, for treatment of Wilson's disease; Medicine for the treatment of Wilson's disease; Medicinal substances, namely, therapeutic Read More
Pharmaceutical preparations for the treatment of Wilson's disease; Pharmaceutical products for the treatment of Wilson's disease; Chemical preparations for medical purposes, namely, for treatment of Wilson's disease; Chemical preparations for pharmaceutical purposes, namely, for treatment of Wilson's disease; Medicine for the treatment of Wilson's disease; Medicinal substances, namely, therapeutic medication for the treatment of Wilson's disease; Medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products and medicines for the treatment of Wilson's disease
28th Mar 2023
28th Mar 2023
No 97059705
No Service/Collective Mark
No 008219.00135
No
No
No
No
No
No
No
No
09.01.04 -
Ribbons, bows
Status Date | Action Taken |
---|---|
06th Jun 2023 | REGISTERED-PRINCIPAL REGISTER |
06th Jun 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
06th May 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
05th May 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
04th May 2023 | ASSIGNED TO EXAMINER |
27th Apr 2023 | STATEMENT OF USE PROCESSING COMPLETE |
27th Apr 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
07th Apr 2023 | USE AMENDMENT FILED |
07th Apr 2023 | TEAS STATEMENT OF USE RECEIVED |
18th Oct 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |